Skip to main content
Back to Sequoia Capital

Sequoia Capital's Therapeutics Portfolio

Browse 14 Therapeutics companies funded by Sequoia Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
14
Total Funding in Therapeutics
$1.9B

Therapeutics Portfolio Companies (14)

Export
Artificial Intelligence (AI)BiotechnologyGenerative AIGeneticsHealth CareTherapeutics

Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.

San Francisco, United States
August 2021
$5.4M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologymHealthPersonal HealthPredictive AnalyticsTelehealthTherapeutics

Biofourmis is a biotechnology company that develops healthcare technology platforms for monitoring patients at home.

Boston, United States
July 2022
$20.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

South San Francisco, United States
May 2026
$115.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareTherapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.

South San Francisco, United States
April 2024
$1.0B
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalMental HealthmHealthTherapeutics

Grow Therapy offers online therapy services that connects individuals with licensed therapists to support mental health.

New York, United States
March 2026
$150.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingMedicalTherapeutics

GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.

San Francisco, United States
March 2023
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

San Francisco, United States
February 2024
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsPharmaceuticalTherapeutics

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

South San Francisco, United States
January 2024
$24.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMedical DeviceMental HealthTherapeutics

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

Palo Alto, United States
December 2021
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareTherapeutics

PhenomeX is a provider of life sciences that have the era of the phenome as the next revolution in biology and medicine unfolds.

Emeryville, United States
January 2023
$70.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

San Diego, United States
November 2025
$100.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore Sequoia Capital's Full Portfolio

View all companies funded by Sequoia Capital across every industry and funding stage.

View Full Sequoia Capital Portfolio